A sensitive and selective HPLC method for estimation of lamotrigine in human plasma and saliva: Application to plasma-saliva correlation in epileptic patients

Arzneimittel-Forschung/Drug Research

Volumn 60, Issue 10, 2010, Pages 599-606

  Mallayasamy, Surulivel Rajan ^a   Arumugam, Karthik ^a   Jain, Tarun ^a   Rajakannan, Thiyagu ^a   Bhat, Krishnamurthy ^a   Gurumadhavrao, Padma ^a   Devarakonda, Ramakrishna ^b  

^a MANIPAL COLLEGE OF PHARMACEUTICAL SCIENCES   (India)

^b MALLINCKRODT PHARMACEUTICALS   (United States)

Author keywords

Antiepileptic drug; CAS 84057 84 1; HPLC method; Lamotrigine, pharmacokinetics, plasma saliva correlation

Indexed keywords

AMMONIUM ACETATE; BUFFER; CARBAMAZEPINE; CAS 28721 07 05; CAS 84057 84 1; LAMOTRIGINE; UNCLASSIFIED DRUG;

ACCURACY; ARTICLE; BLOOD ANALYSIS; CALIBRATION; CONTROLLED STUDY; DRUG ANALYSIS; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG SALIVA LEVEL; DRUG STABILITY; EPILEPSY; FLOW RATE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; PH; REVERSED PHASE LIQUID CHROMATOGRAPHY; SALIVA ANALYSIS; SENSITIVITY AND SPECIFICITY; VALIDATION PROCESS;

EID: 78049343827     PISSN: 00044172     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0031-1296332     Document Type: Article

References (27)

1. Gidal BE, Sheth R, Parbell J, Maloney JK, Sale M. Evaluation of valproate dose and concentration effects on lamotrigine pharmacokinetics: implications for conversion to lamotrigine monotherapy. Epilepsy Res. 2003;57:85-93.
2. Lamictal prescriping information. [Internet] Glaxo-SmithKlineBeecham; 1994 [updated September 2009; cited 2009 Dec 26] [about 4 screens]. Available from: http://us.gsk.com/product /assets/us-lamictal.pdf.
3. Chkhartishvili D, Natriashvili G. Lamotrigine monotherapy for pharmacoresistant complex partial seizures in children with hippocampal atrophy. Clin Neurophysiol. 1996;117(Suppl 1):127-9.
4. Kilpatrick ES, Forrest G, Brodie MJ. Concentration-effect and concentration-toxicity relations with lamotrigine: a prospective study. Epilepsia. 2001;42:1255-60.
5. Hirsch LJ, Weintraub D, Du Y, BauchsbaumR, Spencer HT, Hager M, et al. Correlating lamotrigine concentrations with tolerability in patients with epilepsy. Neurology. 2004;63:1022-6.
6. Incecayir T, Agabeyoglu I, Gucuyener K. Comparison of plasma and saliva concentrations of lamotrigine in healthy volunteers. Arzneimittelforschung. 2007;57(8):517-21.
7. Malone SA, Eadie MJ, Addison RS, Wright AW, Dickinson RG. Monitoring salivary lamotrigine concentrations. J Clin Neurosci. 2006;3(9):902-7.
8. Ryan M, Grim SA, Miles MV, P. Tang PH, Fakhoury TA, Strawsburg RH, et al. Correlation of lamotrigine concentrations between serum and saliva. Pharmacotherapy. 2003;23(12):1550-7.
9. Trnavska Z, Krejcova H, Tkaczykovam, Salcmanova Z, Elis J. Pharmacokinetics of lamotrigine (Lamictal) in plasma and saliva. Eur J Drug Metab Pharmacokinet. 1991;3:211-5.
10. Tsiropouolos I, Kristensen O, Klitgaard NA. Saliva and serum concentration of lamotrigine in patients with epilepsy. Ther Drug Monit. 2000;22:517-21.
11. Vermeij TAC, Edelbroek PM. Robust isocratic high performance liquid chromatographic method for simultaneous determination of seven antiepileptic drugs including lamotrigine, oxcarbazepine and zonisamide in serumafter solidphase extraction. J Chromatogr B. 2007;828(1-2):85-93.
12. Bugamelli F, Sabbioni C, Mandrioli R, Kenndler E , Albani F, Raggi MA. Simultaneous analysis of six antiepileptic drugs and two selected metabolites in human plasma by liquid chromatography after solid-phase extraction. Anal Chim Acta. 2002;472(1):1-10.
13. Yamashita S, Furuno K, Kawasaki H, Gomita Y, Yoshinaga H, Yamatogi Y, et al. Simple and rapid analysis of lamotrigine, a novel antiepileptic, in human serum by high-performance liquid chromatography using a solid-phase extraction technique. J Chromatogr B. 1995;670(2):354-7.
14. Castel-Branco MM, Almeida AM, Falcão AC, Macedo TA, Caramona MM, Lopez FG. Lamotrigine analysis in blood and brain by high-performance liquid chromatography. J Chromatogr B. 2001;755(1-2):119-27.
15. Manuela C, Monica B, Erica C, Carmina C, Fiorenzo A, Roberto R, et al. Simultaneous liquid chromatographic determination of lamotrigine, oxcarbazepine monohydroxy derivative and felbamate in plasma of patients with epilepsy. J Chromatogr B. 2005;828:113-7.
16. Matar KM, Nicholls PJ, Bawazir SA, Al-Hassan MI, Tekle A. A rapid liquid chromatographic method for the determination of lamotrigine in plasma. J Pharm Biomed Anal. 1998;17:525-531.
17. Patil KM and Bodhankar SL. Simultaneous determination of lamotrigine, phenobarbitone, carbamazepine and phenytoin in human serum by high-performance liquid chromatography. J Pharm Biomed Anal. 2005;39(1-2):181-186.
18. Ching LC, Chen HC, Oliver YP. Determination of lamotrigine in small volumes of plasma by high-performance liquid chromatography. J Chromatogr B. 2005;828:113-7.
19. Angelis SP, Morgan DJ, O'Brien TJ, Vajda FJE. Determination of lamotrigine in human plasma by high-performance liquid chromatography. J Chromatogr B. 1999;727:113-8.
20. Londero D, Greco PL. New micro method for the determination of lamotrigine in human plasma by high-performance liquid chromatography. J Chromatogr B. 1997;691:139-44.
21. Bompadre S, Tagliabracci A, Battino M, Giorgetti R. Determination of lamotrigine in whole blood with on line solid phase extraction. J Chromatogr B. 2008;863(1):177-80.
22. Torra M, Rodamilans M, Arroyo S, Corbella J. Optimized procedure for lamotrigine analysis in serum by high-performance liquid chromatography without interferences from other frequently co-administered anticonvulsants. Ther Drug Monit. 2000;22(5):621-5.
23. Croci D, Salmaggi A, De Grazia U, Bernardi G. New highperformance liquid chromatographic method for plasma/serumanalysis of lamotrigine. Ther Drug Monit. 2001;23(6):665-8.
24. Sallustio BC, Morris RG. High-performance liquid chromatography quantitation of plasma lamotrigine concentrations: application measuring trough concentrations in patients with epilepsy. Ther Drug Monit. 1997;19(6):688-93.
25. Dichter MA, Brodie MJ. New antiepileptic drugs. N Engl J Med. 1996;334:1583-90.
26. Morris RG, Black AB, Harris AL, Batty AB, Sallustio BC. Lamotrigine and therapeutic drug monitoring: retrospective survey following the introduction of a routine service. Br J Clin Pharmacol. 1998;46:547-51.
27. Guidance for industry. Bioanalytical method validation [Internet]. Bethesda (MD): Food and Drug Administration, Center for Drug Evaluation and Research, (US); May 2001[cited 2009 Dec 26] [about 25 screens]. Available from: http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/ Guidances/UCM070107.pdf.